ClinicalTrials.Veeva

Menu

Efficacy of Buteyko Breathing in Seniors With Chronic Eustachian Tube Dysfunction

Cairo University (CU) logo

Cairo University (CU)

Status

Enrolling

Conditions

Eustachian Tube Dysfunction

Treatments

Other: usual care
Other: Buteyko breathing

Study type

Interventional

Funder types

Other

Identifiers

NCT07193485
IRB00014233-36

Details and patient eligibility

About

Eustachian tube dysfunction is distressing probelm. drugs usually are not effective. compelemtary tehrapies like Buteyko breathing may be effective

Full description

forty seniors with Eustachian tube dysfunction (chronic obstructive form) will be ranomized to group I or group II. the group enroled 20 seniors. both groups wil take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks. group I will aslo receive 30-min Buteyko breathing two times daily for 14 weeks.

Enrollment

40 estimated patients

Sex

All

Ages

65 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Eustachian Tube Dysfunction (chronic obstructive form)
  • unilateral ear affetion
  • senior patients
  • chronci affection more than 3 months

Exclusion criteria

  • obesity
  • cardiac probelms repsiratory problems

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups

group number 1
Experimental group
Description:
twenty seniors with Eustachian tube dysfunction (chronic obstructive form) will bein group I and this group will take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks. Also, group I will aslo receive 30-min Buteyko breathing two times daily for 14 weeks.
Treatment:
Other: Buteyko breathing
group number 2
Active Comparator group
Description:
Twenty seniors with Eustachian tube dysfunction (chronic obstructive form) will be ranomized to group II oand this group will take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks.
Treatment:
Other: usual care

Trial contacts and locations

1

Loading...

Central trial contact

Ali mohamed, lecturer; Ali MA Ismail, lecturer

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems